Viatris (VTRS) Notes Payables (2020 - 2023)
Viatris (VTRS) posted Notes Payables of $100000.0 for Q3 2023, down 99.57% on a QoQ basis from $23.2 million in Q2 2023, and down 99.98% year-over-year from $500.4 million in Q3 2022.
Analysis
Viatris (VTRS) Notes Payables (2020 - 2023) Analysis & Trends
Viatris has reported Notes Payables for 4 years, with the latest figure at $100000.0 in Q3 2023.
- On a quarterly basis, Notes Payables fell 99.98% year-over-year to $100000.0 in Q3 2023; TTM through Sep 2023 was $100000.0, a 99.98% decrease from a year earlier, with the FY2021 full-year figure at $1.5 billion, up 35.62% from the prior year.
- Notes Payables was $100000.0 for Q3 2023 at Viatris, down from $23.2 million in the prior quarter.
- The five-year high for Notes Payables was $1.7 billion in Q3 2021, with the low at $100000.0 in Q3 2023.
- Average Notes Payables over 4 years is $731.4 million, with a median of $655.4 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2023: Notes Payables jumped 1676.15% in 2022, then sank 99.98% in 2023.
- Over 4 years, Notes Payables stood at $1.1 billion in 2020, then soared by 35.62% to $1.5 billion in 2021, then sank by 66.48% to $500.4 million in 2022, then tumbled by 99.98% to $100000.0 in 2023.
- The last three Notes Payables figures came in at $100000.0 (Q3 2023), $23.2 million (Q2 2023), and $204.6 million (Q1 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 23.20 Mn |
| Mar 31, 2023 | 204.60 Mn |
| Sep 30, 2022 | 500.40 Mn |
| Jun 30, 2022 | 1.02 Bn |
| Mar 31, 2022 | 655.40 Mn |
| Dec 31, 2021 | 1.49 Bn |
| Sep 30, 2021 | 1.71 Bn |
| Jun 30, 2021 | 1.30 Bn |
| Mar 31, 2021 | 36.90 Mn |
| Dec 31, 2020 | 1.10 Bn |